Showing 1 - 4 results of 4 for search 'William B. Slayton', query time: 0.03s Refine Results
  1. 1
    Incidence and Risk Factors for 30-Day Readmission after Inpatient Chemotherapy among Acute Lymphoblastic Leukemia Patients

    Incidence and Risk Factors for 30-Day Readmission after Inpatient Chemotherapy among Acute Lymphoblastic Leukemia Patients by Phuong T. Tran, William B. Slayton, Mansi Dalal, Joshua Brown

    Published 2020-10-01
    Get full text
    Article
  2. 2
    Conditional deletion of Jak2 reveals an essential role in hematopoiesis throughout mouse ontogeny: implications for Jak2 inhibition in humans.

    Conditional deletion of Jak2 reveals an essential role in hematopoiesis throughout mouse ontogeny: implications for Jak2 inhibition in humans. by Sung O Park, Heather L Wamsley, Kyungmi Bae, Zhongbo Hu, Xiaomiao Li, Se-woon Choe, William B Slayton, S Paul Oh, Kay-Uwe Wagner, Peter P Sayeski

    Published 2013-01-01
    Get full text
    Article
  3. 3
    Two novel RUNX1 mutations in a patient with congenital thrombocytopenia that evolved into a high grade myelodysplastic syndrome

    Two novel RUNX1 mutations in a patient with congenital thrombocytopenia that evolved into a high grade myelodysplastic syndrome by Jessica M. Schmit, Daniel J. Turner, Robert A. Hromas, John R. Wingard, Randy A. Brown, Ying Li, Marilyn M. Li, William B. Slayton, Christopher R. Cogle

    Published 2015-01-01
    Get full text
    Article
  4. 4
    Primary pulmonary artery sarcoma in the pediatric patient: Review of literature and a case report

    Primary pulmonary artery sarcoma in the pediatric patient: Review of literature and a case report by Yong Yean Kim, MD, PhD, Tung Thanh Wynn, MD, John David Reith, MD, William B. Slayton, MD, Joanne Lagmay, MD, John Fort, MD, Dhanashree Abhijit Rajderkar, MD

    Published 2020-07-01
    Get full text
    Article

Search Tools: